Aclaris Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax
Aclaris Therapeutics, Inc. (ACRS) reported Other Comprehensive Income (Loss), Net of Tax of -$326.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$326.00K, a 779.17% decline year-over-year.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$588.00K, a 274.48% decline year-over-year.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $13.00K.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $115.00K, a 87.08% decline year-over-year.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $513.00K, a 152.71% increase from fiscal 2024.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $203.00K, a 74.34% decline from fiscal 2023.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $791.00K.
- Aclaris Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$673.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$326.00K 10-Q · filed 2026-08-06 | -$914.00K 10-Q · filed 2026-08-06 | -$901.00K derived: sum of 3 quarters · filed 2026-08-06 | -$786.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$588.00K 10-Q · filed 2026-05-07 | -$575.00K derived: sum of 2 quarters · filed 2026-05-07 | -$460.00K derived: sum of 3 quarters · filed 2026-05-07 | -$412.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $128.00K derived: sum of 2 quarters · filed 2026-02-26 | $176.00K derived: sum of 3 quarters · filed 2026-08-06 | $513.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $115.00K 10-Q · filed 2025-11-06 | $163.00K derived: sum of 2 quarters · filed 2026-08-06 | $500.00K 10-Q · filed 2025-11-06 | $170.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $48.00K 10-Q · filed 2026-08-06 | $385.00K 10-Q · filed 2026-08-06 | $55.00K derived: sum of 3 quarters · filed 2026-08-06 | $945.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $337.00K 10-Q · filed 2026-05-07 | $7.00K derived: sum of 2 quarters · filed 2026-05-07 | $897.00K derived: sum of 3 quarters · filed 2026-05-07 | $798.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $560.00K derived: sum of 2 quarters · filed 2026-02-26 | $461.00K derived: sum of 3 quarters · filed 2026-02-26 | $203.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $890.00K 10-Q · filed 2025-11-06 | $791.00K derived: sum of 2 quarters · filed 2025-11-06 | $533.00K 10-Q · filed 2025-11-06 | $1.56M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$99.00K 10-Q · filed 2025-08-07 | -$357.00K 10-Q · filed 2025-08-07 | $666.00K derived: sum of 3 quarters · filed 2025-08-07 | $648.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$258.00K 10-Q · filed 2025-05-08 | $765.00K derived: sum of 2 quarters · filed 2025-05-08 | $747.00K derived: sum of 3 quarters · filed 2025-05-08 | -$10.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.00M derived: sum of 2 quarters · filed 2025-02-27 | $248.00K derived: sum of 3 quarters · filed 2025-02-27 | $791.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$18.00K 10-Q · filed 2024-11-06 | -$775.00K derived: sum of 2 quarters · filed 2024-11-06 | -$232.00K 10-Q · filed 2024-11-06 | $336.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$757.00K 10-Q · filed 2024-08-07 | -$214.00K 10-Q · filed 2024-08-07 | $354.00K derived: sum of 3 quarters · filed 2024-08-07 | $215.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $543.00K 10-Q · filed 2024-05-07 | $1.11M derived: sum of 2 quarters · filed 2024-05-07 | $972.00K derived: sum of 3 quarters · filed 2024-05-07 | $618.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $429.00K derived: sum of 2 quarters · filed 2024-02-27 | $75.00K derived: sum of 3 quarters · filed 2024-02-27 | -$673.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | -$139.00K 10-Q · filed 2023-11-06 | -$493.00K derived: sum of 2 quarters · filed 2023-11-06 | -$1.24M 10-Q · filed 2023-11-06 | -$1.46M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$354.00K 10-Q · filed 2023-08-07 | -$1.10M 10-Q · filed 2023-08-07 | -$1.32M derived: sum of 3 quarters · filed 2024-02-27 | -$1.14M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$748.00K 10-Q · filed 2023-05-08 | -$969.00K derived: sum of 2 quarters · filed 2024-02-27 | -$788.00K derived: sum of 3 quarters · filed 2024-02-27 | -$832.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$40.00K derived: sum of 2 quarters · filed 2024-02-27 | -$84.00K derived: sum of 3 quarters · filed 2024-02-27 | -$130.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $181.00K 10-Q · filed 2022-11-08 | $137.00K derived: sum of 2 quarters · filed 2022-11-08 | $91.00K 10-Q · filed 2022-11-08 | $42.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$44.00K 10-Q · filed 2022-08-03 | -$90.00K 10-Q · filed 2022-08-03 | -$139.00K derived: sum of 3 quarters · filed 2023-02-23 | -$199.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$46.00K 10-Q · filed 2022-05-10 | -$95.00K derived: sum of 2 quarters · filed 2023-02-23 | -$155.00K derived: sum of 3 quarters · filed 2023-02-23 | -$187.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$109.00K derived: sum of 2 quarters · filed 2023-02-23 | -$141.00K derived: sum of 3 quarters · filed 2023-02-23 | -$28.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | -$60.00K 10-Q · filed 2021-11-02 | -$92.00K derived: sum of 2 quarters · filed 2021-11-02 | $21.00K 10-Q · filed 2021-11-02 | -$44.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$32.00K 10-Q · filed 2021-08-05 | $81.00K 10-Q · filed 2021-08-05 | $16.00K derived: sum of 3 quarters · filed 2022-02-24 | $7.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $113.00K 10-Q · filed 2021-05-07 | $48.00K derived: sum of 2 quarters · filed 2022-02-24 | $39.00K derived: sum of 3 quarters · filed 2022-02-24 | $96.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$74.00K derived: sum of 2 quarters · filed 2022-02-24 | -$17.00K derived: sum of 3 quarters · filed 2022-02-24 | $3.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | -$9.00K 10-Q · filed 2020-11-04 | $48.00K derived: sum of 2 quarters · filed 2020-11-04 | $68.00K 10-Q · filed 2020-11-04 | $115.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $57.00K 10-Q · filed 2020-08-07 | $77.00K 10-Q · filed 2020-08-07 | $124.00K derived: sum of 3 quarters · filed 2021-02-25 | $196.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $20.00K 10-Q · filed 2020-05-07 | $67.00K derived: sum of 2 quarters · filed 2021-02-25 | $139.00K derived: sum of 3 quarters · filed 2021-02-25 | $278.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $119.00K derived: sum of 2 quarters · filed 2021-02-25 | $258.00K derived: sum of 3 quarters · filed 2021-02-25 | $177.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $72.00K 10-Q · filed 2019-11-07 | $211.00K derived: sum of 2 quarters · filed 2019-11-07 | $130.00K 10-Q · filed 2019-11-07 | -$4.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $139.00K 10-Q · filed 2019-08-08 | $58.00K 10-Q · filed 2019-08-08 | -$76.00K derived: sum of 3 quarters · filed 2020-02-25 | -$23.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$82.00K 10-Q · filed 2019-05-08 | -$215.00K derived: sum of 2 quarters · filed 2020-02-25 | -$162.00K derived: sum of 3 quarters · filed 2020-02-25 | -$79.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$80.00K derived: sum of 2 quarters · filed 2020-02-25 | $3.00K derived: sum of 3 quarters · filed 2020-02-25 | $23.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $53.00K 10-Q · filed 2018-11-06 | $136.00K derived: sum of 2 quarters · filed 2018-11-06 | $156.00K 10-Q · filed 2018-11-06 | -$59.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $83.00K 10-Q · filed 2018-08-03 | $103.00K 10-Q · filed 2018-08-03 | -$112.00K derived: sum of 3 quarters · filed 2019-03-18 | -$167.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-08 | -$195.00K derived: sum of 2 quarters · filed 2019-03-18 | -$250.00K derived: sum of 3 quarters · filed 2019-03-18 | -$252.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | -$215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$270.00K derived: sum of 2 quarters · filed 2019-03-18 | -$272.00K derived: sum of 3 quarters · filed 2019-03-18 | -$120.00K 10-K · filed 2019-03-18 |
| 2016-09-30 | -$55.00K 10-Q · filed 2017-11-07 | -$57.00K derived: sum of 2 quarters · filed 2017-11-07 | $95.00K 10-Q · filed 2017-11-07 | -$55.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$2.00K 10-Q · filed 2017-08-08 | $150.00K 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-12 | $1.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $152.00K 10-Q · filed 2017-05-09 | $2.00K derived: sum of 2 quarters · filed 2018-03-12 | $3.00K derived: sum of 3 quarters · filed 2018-03-12 | $6.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$149.00K derived: sum of 2 quarters · filed 2018-03-12 | -$146.00K derived: sum of 3 quarters · filed 2018-03-12 | -$143.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-03 | $4.00K derived: sum of 2 quarters · filed 2016-11-03 | $7.00K 10-Q · filed 2016-11-03 | $1.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $3.00K 10-Q · filed 2016-08-11 | $6.00K 10-Q · filed 2016-08-11 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | -$3.00K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $3.00K 10-Q · filed 2016-05-11 | -$3.00K derived: sum of 2 quarters · filed 2017-03-15 | -$6.00K derived: sum of 3 quarters · filed 2017-03-15 | |
| 2014-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$9.00K derived: sum of 2 quarters · filed 2017-03-15 | -$9.00K 10-K · filed 2017-03-15 | |
| 2014-09-30 | -$3.00K 10-Q · filed 2015-12-03 | -$3.00K 10-Q · filed 2015-12-03 | ||
| 2013-12-31 | $3.00K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |